ARCHIVED      Text Version     PDF Version     To Publication Page     To Home Page

To Home Page.


National Drug Intelligence Center.



New Jersey Drug Threat Assessment Update

New Jersey Drug Threat Assessment Update.Publication Date: April 2004

Document ID: 2004-S0378NJ-001

Available New Jersey Assessments
   2004 Update: April 2004
2002 Update: August 2002
Original: May 2001

Archived on:  January 1, 2006. This document may contain dated information. It remains available to provide access to historical materials.

This report is a brief update to the New Jersey Drug Threat Assessment, which is a strategic assessment of the status and outlook of the drug threat to New Jersey. Analytical judgment determined the threat posed by each drug type or category, taking into account the most current quantitative and qualitative information on availability, demand, production or cultivation, transportation, and distribution, as well as the effects of a particular drug on abusers and society as a whole. While NDIC sought to incorporate the latest available information, a time lag often exists between collection and publication of data. NDIC anticipates that this update will be useful to policymakers, law enforcement personnel, and treatment providers at the federal, state, and local levels. 

The August 2002 New Jersey Drug Threat Assessment Update and the May 2001 New Jersey Drug Threat Assessment are available on NDIC's web site or by contacting the NDIC dissemination line at 814-532-4541.

Your questions, comments, and suggestions for future subjects are welcome at any time.  Addresses are provided at the end of the page.
Flag image Stockbyte.







Other Dangerous Drugs
  GHB and Analogs
  Diverted Pharmaceuticals




List of Tables 

Table 1. Drug-Related Emergency Department Mentions, Newark, 2001-2002


New Jersey.

Map of New Jersey showing major transportation routes.

Drug traffickers use New Jersey, particularly metropolitan areas such as Newark and Camden, as a regional drug transshipment and distribution center. The state's well-developed transportation infrastructure is ideally suited for the movement of illicit goods, and the proximity of New York City and Philadelphia leave New Jersey vulnerable to drug transportation from these cities. Drugs transported by truck, private vehicle, railcar, maritime vessel, aircraft, and package delivery services have an excellent chance of reaching their destinations because of the volume of traffic moving into and through the state daily. The rural areas, particularly those in southern and western New Jersey, are conducive to cannabis cultivation.

Cocaine, particularly crack cocaine, is readily available throughout New Jersey, and the drug's distribution and abuse are linked to more violent crime than any other illicit substance, making cocaine the state's primary drug threat. The distribution and abuse of heroin, primarily low cost, high purity South American heroin, pose nearly as serious a threat as cocaine. Health consequences associated with heroin abuse are significantly greater than for any other drug in the state. Marijuana is widely available and commonly abused in New Jersey; however, marijuana is not readily associated with violence or deaths, as are cocaine and heroin. Other dangerous drugs are available to varying extent in New Jersey, but the availability of MDMA in particular is high and indications are that organized criminal groups are becoming more involved in MDMA distribution in the state. The diversion of pharmaceuticals such as OxyContin is a rapidly emerging threat to New Jersey. The production and abuse of methamphetamine pose a low threat to the state.


National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901

Tel. (814) 532-4601
FAX (814) 532-4690

National Drug Intelligence Center
8201 Greensboro Drive, Suite 1001
McLean, VA 22102-3840

Tel. (703) 556-8970
FAX (703) 556-7807


Web Addresses

ADNET:  http://ndicosa 

To Top     To Contents     To Next Page

To Publication Page     To Home Page

End of page.